Arkolith/Insider Trading/VRCA/Form 4

Goldenberg Gary

Chief Medical OfficerVerrica Pharmaceuticals Inc. (VRCA) · full profile →Form 4 · filed Nov 16, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$26K
Net Open-Market Flow
-$26K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 15, 2023Sell(S)3K$2.97$9K86K
Nov 14, 2023Sell(S)6K$2.93$17K89K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-055534) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML